A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-520385-57-01

Acronym

TNT119-SLE-101

Enrollment

Registered

2025-10-31

Start date

2025-11-26

Completion date

Unknown

Last updated

2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, Greece, Romania, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026